Enter search term

Viral hepatitis

Discover our comprehensive services for the diagnosis and treatment of viral hepatitis. Our specialized services provide support for patients with Hepatitis B and C, along with individualized treatment plans for optimal care.

Viral hepatitis

Hepatitis B

Hepatitis B is a liver inflammation caused by the Hepatitis B virus. In adults, a Hepatitis B infection typically progresses acutely, with the body usually able to fight off the virus on its own, resulting in functional healing.

However, in up to 10% of cases, Hepatitis B becomes chronic, meaning the virus remains detectable in the blood 6 months after infection, and these individuals can infect others. Patients with chronic Hepatitis B are at increased risk of liver cirrhosis and liver cancer.

Diagnosis and Treatment

Treatment for chronic Hepatitis B can last for months or years, often requiring lifelong medication. In cases of concurrent HIV and Hepatitis infection ("coinfection"), HIV and Hepatitis therapies must be coordinated.

While Hepatitis B is typically incurable, timely treatment can reduce the risk of developing liver cirrhosis or liver cancer.

Hepatitis C

Chronic Hepatitis C is a liver disease caused by the Hepatitis C virus. Left untreated, it can lead to serious health problems. Thanks to new medications, the disease is now rapidly and effectively curable in nearly all patients and is well tolerated.


A Hepatitis C infection often goes unnoticed or is not immediately recognized. Three to six months after infection, symptoms such as fatigue, upper abdominal discomfort, decreased performance, itching, and joint pain may occur. Sometimes, there is yellowing of the (mucous) skin or eyes. Some infections resolve spontaneously after a few weeks, but many become chronic and require treatment to prevent severe complications such as liver cirrhosis and liver cancer.

Diagnosis and Treatment

Hepatitis C is now fully curable in almost all patients, often within a few weeks and with few side effects, thanks to innovative medications. Hepatitis C therapy now relies on direct-acting antivirals (DAAs), which effectively block virus replication. These new agents are also effective against all 6 virus or genotype variations, allowing nearly every patient with chronic Hepatitis C to be cured.

Current Studies in Hepatitis B and C

None at the moment